You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BLRM (Bayesian Logistic Regression Model)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colorectal Cancer, Colorectal Polyp, Colorectal Adenoma Trial in Oakland (Logistic regression risk model)

Enrolling by invitation
  • Colorectal Cancer
  • +3 more
  • Logistic regression risk model
  • Oakland, California
    Kaiser Permanente Northern California Division of Research
Nov 3, 2022

Prediction Model for PICC Catheter Displacement

Active, not recruiting
  • Cancer Patients With PICC
  • Logistic Regression Analysis
  • Hangzhou, Zhejiang, China
    2nd Affilicated Hospital, School of Medicine, Zhejiang Universit
Jun 10, 2021

Solid Tumor With p53 Wild Type Status Trial in Worldwide (CGM097)

Completed
  • Solid Tumor With p53 Wild Type Status
  • Boston, Massachusetts
  • +4 more
Jun 10, 2021

Colorectal Cancer, Colorectal Carcinoma, Colorectal Tumors Trial in Amsterdam (Risk-based logistic regression model, FIT)

Completed
  • Colorectal Cancer
  • +4 more
  • Risk-based logistic regression model
  • FIT
  • Amsterdam, Noord-Holland, Netherlands
    Amsterdam UMC, locatie Academisch Medisch Centrum
Aug 12, 2021

Solid Tumor, Adult, Advanced Solid Tumor, Advanced Renal Cell Carcinoma Trial in Australia (89Zr-TLX250, 177Lu-TLX250 and

Recruiting
  • Solid Tumor, Adult
  • +2 more
  • 89Zr-TLX250
  • 177Lu-TLX250 and Peposertib
  • North Ryde, New South Wales, Australia
  • +4 more
May 22, 2023

Advanced Solid and Hematological TP53wt Tumors Trial in Worldwide (HDM201, ancillary treatment)

Completed
  • Advanced Solid and Hematological TP53wt Tumors
  • Boston, Massachusetts
  • +14 more
May 20, 2021

Multiple Myeloma, Plasma Cell Disorder Trial in Germany, United States (HDP-101)

Recruiting
  • Multiple Myeloma
  • Plasma Cell Disorder
  • Atlanta, Georgia
  • +5 more
Mar 10, 2022

Acute Myeloid Leukemia (AML) Relapse Trial in Freiburg, Münster (F16IL2, BI 836858)

Completed
  • Acute Myeloid Leukemia (AML) Relapse
  • Freiburg, Germany
  • +1 more
Apr 13, 2022

New Psychoactive Substances Using in Adolescents

Not yet recruiting
  • Drug Addiction
  • Questionnaires
  • Guangzhou, Guangdong, China
    Sun Yat-sen University
Jul 21, 2023

Radiation Optic Neuropathy

Completed
  • Optic Radiation Neuropathy Following Radiotherapy Procedure
  • head and neck radiation
  • Guangzhou, China
    Zijing Li
May 29, 2023

Tumor Trial in Chuo-Ku, Kashiwa (JNJ-63723283, Erdafitinib)

Completed
  • Neoplasm
  • Chuo-Ku, Japan
  • +1 more
Nov 3, 2022

Advanced NSCLC Trial in Worldwide (EGF816)

Active, not recruiting
Has Results
  • Advanced Non-small Cell Lung Cancer
  • Boston, Massachusetts
  • +13 more
Oct 21, 2022

Advanced Malignant Solid Tumor Trial in France, Netherlands (MP0317, a tri-specific fibroblast activation protein (FAP) x CD40

Recruiting
  • Advanced Malignant Solid Tumor
  • MP0317, a tri-specific fibroblast activation protein (FAP) x CD40 DARPin® drug candidate
  • Lyon, Cedex 08, France
  • +3 more
Nov 4, 2022

New Prognostic Index for Neoadjuvant Chemotherapy Outcome in

Enrolling by invitation
  • Ovarian Cancer
  • +2 more
  • CRS scoring
  • Routine blood laboratory testing before treatment
  • Guangzhou, Guangdong, China
    The Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Nov 2, 2023

Para-aortic Lymph Node Metastasis of Cervical Cancer

Completed
  • Locally Advanced Cervical Cancer
  • surgical staging
  • Chongqing, Chongqing, China
    Chongqing University Cancer Hospital
Jan 29, 2023

Solid Tumor, Adult Trial in Boston, Canton, Houston (HB0045 Drug Product)

Not yet recruiting
  • Solid Tumor, Adult
  • HB0045 Drug Product
  • Boston, Massachusetts
  • +2 more
Jul 5, 2023

Nomogram Predicting Probability of in Hirschsprung Children

Completed
  • Develop a Nomogram
  • training set
  • Wuhan, Hubei, China
    Tongji hospital affiliated to tongji medical college of huazhong
Sep 2, 2023

Solid Tumor, Adult Trial in Boston, Canton, Houston (HB0045 Drug Product)

Not yet recruiting
  • Solid Tumor, Adult
  • HB0045 Drug Product
  • Boston, Massachusetts
  • +2 more
Sep 20, 2023

Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer,

Recruiting
  • Locally Advanced or Metastatic ER+ HER2- Breast Cancer
  • +2 more
  • Scottsdale, Arizona
  • +45 more
Dec 11, 2022

Apical Periodontitis, Caries, Lifestyle Trial in Siena

Completed
  • Apical Periodontitis
  • +4 more
    • Siena, Italy
      Azienda Ospedaliera Universitaria Senese
    Oct 2, 2023

    Metastatic Pancreatic Ductal Adenocarcinoma Trial in Boston, New York (Canakinumab injection; spartalizumab, nab-paclitaxel,

    Active, not recruiting
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • Canakinumab injection; spartalizumab, nab-paclitaxel, gemcitabine
    • Boston, Massachusetts
    • +1 more
    Apr 5, 2022

    Three Randomised Clinical Trials of Intraoperative Ventilation

    Active, not recruiting
    • Mechanical Ventilation Complication
    • +3 more
    • High PEEP + Recruitment maneuvers
    • Sao Paulo, Brazil
    • +3 more
    Jun 4, 2023

    Multiple Myeloma Trial in Worldwide (CC-99712, BMS-986405)

    Recruiting
    • Multiple Myeloma
    • La Jolla, California
    • +38 more
    Jan 3, 2023

    Different Ultrasound Methods for Discrimination Between Benign

    Unknown status
    • Patients With Adnexal Mass Prior to Surgery
    • Standardized transvaginal ultrasound examination
    • Leuven, Belgium
      University Hospitals Leuven
    Apr 12, 2020

    LSCI and Thermography in Diabetic Foot Patients Affected by

    Not yet recruiting
    • Diabetes Mellitus, Type 2
    • +2 more
      • (no location specified)
      Mar 30, 2023